Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

Washington State Sues OxyContin Maker Purdue Pharma

Nate Raymond  |  September 29, 2017

(Reuters)—Washington state on Thursday sued OxyContin maker Purdue Pharma LP, becoming the latest state or local government to file a lawsuit seeking to hold pharmaceutical companies accountable for a national opioid addiction epidemic. The city of Seattle also filed a separate lawsuit against Purdue as well as units of Teva Pharmaceutical Industries Ltd, Johnson and…

Filed under:Drug UpdatesLegal Updates Tagged with:Allergan Plc.Endo International PlcJohnson and Johnsonnational opioid addiction epidemicopioid crisisOxyContinPurdue Pharma LPTeva Pharmaceutical Industries LtdWashington state lawsuit

Makers of Fast-Acting Opioids Will Have to Pay for Training—FDA

Michael Erman  |  September 29, 2017

NEW YORK (Reuters)—Makers of fast-acting opioids will have to fund voluntary training for healthcare professionals who prescribe the drugs, including education on safe prescribing practices and non-opioid alternatives, the course  said on Thursday. The FDA sent letters to 74 manufacturers of immediate-release opioids, notifying them that they will have to fund the development of courses…

Filed under:Drug UpdatesEducation & Training Tagged with:course fundingfast-acting opioidsopioid drug companiesU.S. Food and Drug Administration (FDA)

Inflammatory Spinal Disorders Common in IBD Patients

Anne Harding  |  September 21, 2017

NEW YORK (Reuters Health)—Ankylosing spondylitis (AS), axial spondyloarthritis (SpA) and inflammatory back pain are common in inflammatory bowel disease (IBD) patients two decades after IBD diagnosis, according to findings from the IBSEN study1. Doctors should know IBD patients are at risk of inflammatory back problems, and refer them to a rheumatologist when appropriate, Dr. Alvilde Ossum…

Filed under:Axial SpondyloarthritisConditions Tagged with:Ankylosing Spondylitisaxial spondyloarthritis (SpA)inflammatory back paininflammatory bowel disease (IBD)Inflammatory Bowel South-Eastern Norway studyinflammatory spinal disorders

Unbudgeted: How the Opioid Crisis Is Blowing a Hole in Small-Town America’s Finances

Paula Seligson & Tim Reid  |  September 20, 2017

INDIANA, Pa./CHILLICOTHE, Ohio (Reuters)—As deaths mount in America’s opioid crisis, communities on the front lines face a hidden toll: the financial cost. Ross County, a largely rural region of 77,000 people an hour south of Columbus, Ohio, is wrestling with an explosion in opioid-related deaths—44 last year compared with 19 in 2009. The drug addiction…

Filed under:AnalgesicsDrug Updates

Rheumatology Advocates Visit D.C. to Act for Arthritis

From the College  |  September 20, 2017

The ACR/ARHP’s annual fly-in to D.C. (#Act4Arthritis) was a huge success. More than 100 ACR/ARHP members and patients from across the nation attended meetings on Capitol Hill to advocate for people living with rheumatic diseases. In all, our advocates visited 138 Senate and House offices. This year’s fly-in on Sept. 25–26 coincided with the second-annual…

Filed under:Legislation & Advocacy Tagged with:Act for ArthritisMedicare therapy capsPatients’ Access to Treatments Act (PATA)pharmacy benefit managers (PBMs)Rheumatic Disease Awareness Month (RDAM)

TNF Inhibitor Drug Tapering Successful in Some Patients with RA

Thomas R. Collins  |  September 19, 2017

MADRID—Scores on the Health Assessment Questionnaire for Rheumatoid Arthritis (HAQ) and C-reactive protein (CRP) levels were independent predictors of whether patients could be tapered successfully from a TNF inhibitor after having reached remission of their RA, according to findings presented in a session at the Annual European Congress of Rheumatology. Researchers also developed a composite…

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:adalimumabAnnual European Congress of RheumatologyClinicaldrugetanerceptEULARglucocorticosteroidMedicationoutcomeResearchRheumatoid arthritistaperingtherapyTNF inhibitorTreatment

Whole-Body MRI, Ultrasound Imaging May Aid in Early Rheumatic Disease Diagnosis, Treatment

Thomas R. Collins  |  September 19, 2017

MADRID—Researchers say that whole-body MRI could yield an earlier diagnosis of spondyloarthropathy (SpA) in patients with early inflammatory joint symptoms, according to findings presented in a poster session at the Annual European Congress of Rheumatology (EULAR). The approach could lead to earlier treatment and better outcomes, they say. Investigators at the University of Leeds recruited…

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Annual European Congress of RheumatologyDiagnosisdiagnostic testingEULARinflammationmagnetic resonance imagingMRIResearchRheumatic DiseaserheumatologyspondyloarthropathyTreatmentUltrasound

Rheumatoid Arthritis Treatments Show Mixed Results

Thomas R. Collins  |  September 19, 2017

MADRID—The anti-IL6 “nanobody,” vobarilizumab, produced mixed results when used with methotrexate (MTX) and compared with MTX and placebo, according to results of a 24-week, double-blind Phase 2b study of patients with rheumatoid arthritis (RA), which were presented in an abstract session at the Annual European Congress of Rheumatology (EULAR). The drug missed its primary endpoint…

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:Annual European Congress of Rheumatologyanti-IL6ClinicalDisease-modifying antirheumatic drugs (DMARDs)drugEULARMedicationMethotrexatenanobodyoutcomeRheumatoid arthritisrheumatologistrheumatologyTreatmentvobarilizumab

Effectiveness of Tofacitinib with Methotrexate, Adalimumab Therapy Evaluated in Patients with RA

Thomas R. Collins  |  September 19, 2017

MADRID—Tofacitinib (a JAK inhibitor) used with methotrexate (MTX) is not inferior to adalimumab (a TNF inhibitor) in rheumatoid arthritis (RA) patients who’ve had an inadequate response to MTX alone, according to results of a Phase 3B/4 trial presented in a session at the Annual European Congress of Rheumatology (EULAR). The findings came in a one-year…

Filed under:ConditionsDrug UpdatesResearch RheumRheumatoid Arthritis Tagged with:adalimumabAnnual European Congress of RheumatologyClinicalDisease-modifying antirheumatic drugs (DMARDs)effectivenessEULARMedicationMethotrexateORAL Strategyoutcomepatient careRAResearchRheumatoid arthritisrheumatologytherapyTofacitinib

Skype-Based Biopsychosocial Treatments Help Save Physical Therapy Patients Time, Trouble

Elizabeth Hofheinz, MPH, MEd  |  September 19, 2017

It’s a bit ironic that when injured people are in pain—and their mobility is reduced—they are often expected to travel to a physical therapy clinic. For millions of people, such trips are a burden. In Australia, however, some patients are “letting movement come to them.” Novel research from The University of Melbourne shows that taking…

Filed under:Practice SupportResearch RheumTechnology Tagged with:biopsychosocialExerciseInternetonlinePain Managementpatient carePhysical TherapyPractice ManagementResearchstudyTreatment

  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 245
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences